Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel approach to combinatorial library design.

Ramaswamy Nilakantan1, Fred Immermann, Kevin Haraki

  • 1Computational Chemistry, Wyeth-Ayerst Research, Pearl River, New York 10965, USA. Nilakar@war.wyeth.com

Combinatorial Chemistry & High Throughput Screening
|April 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.

Arthritis & rheumatology (Hoboken, N.J.)·2017
Same author

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.

Archives of neurology·2012
Same author

MultiMCS: a fast algorithm for the maximum common substructure problem on multiple molecules.

Journal of chemical information and modeling·2011
Same author

A protein relational database and protein family knowledge bases to facilitate structure-based design analyses.

Chemical biology & drug design·2010
Same author

Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxics.

Biomarkers in medicine·2010
Same author

A structural informatics approach to mine kinase knowledge bases.

Drug discovery today·2009

Designing effective pharmaceutical screening libraries requires focusing on pharmaceutically relevant scaffolds. Approximately 50-100 analogs per scaffold are needed to ensure discovery of active drug leads.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Computational Chemistry

Background:

  • Conventional combinatorial libraries prioritize diversity for screening pharmaceutical leads.
  • This approach may be inefficient as many compounds within an active series can be inactive, especially during early optimization stages.

Purpose of the Study:

  • To propose an improved strategy for designing general-purpose combinatorial libraries for pharmaceutical lead screening.
  • To determine the optimal number of analogs per scaffold required for effective hit identification.

Main Methods:

  • Introducing the concept of 'hit-rate within a series' to evaluate library design.
  • Utilizing historical screening data to estimate hit-rates.
  • Applying probability arguments to calculate the necessary number of compounds per series.

Related Experiment Videos

Main Results:

  • A scaffold-based library design with multiple analogs per scaffold is suggested.
  • A crude estimate for 'hit-rate within a series' was derived from historical data.
  • Probability calculations indicate that 50-100 compounds per series are needed for high confidence in finding active compounds.

Conclusions:

  • Scaffold-based library design with sufficient analogs per scaffold enhances the probability of identifying active pharmaceutical leads.
  • The proposed method offers a more targeted and potentially efficient approach to drug discovery screening.
  • This strategy aims to increase the hit-rate and reduce the resources needed in early-stage drug development.